glp-1-based therapy Rethinking GLP-1RA Through the Lens of Glucagon and Resilience GLP-1 therapy is changing the

OVER 6400 FIVE STAR REVIEWS

Broader intermittent fasting protocols achieve 3 to 8 percent weight loss over 6 to 12 months

The Wegovy pill (25 mg) produces an average weight loss of 13.6% in 64 weeks (about a year and three months), according to a study of adults with obesity or overweight

There are no clinical studies on the efficacy, safety, or dosing of GLP-1 patches, but they will likely follow the titrating dosing method, similar to GLP-1 injections

Generally, Aetna requires a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related health condition like high blood pressure, high cholesterol, or sleep apnea

Common side effects could include minor irritation at the application site, redness, or slight itching